KEGG   DRUG: Conatumumab
Entry
D09329                      Drug                                   
Name
Conatumumab (USAN/INN)
Formula
C6466H10006N1730O2024S40
Exact mass
145554.2053
Mol weight
145643.6104
Sequence
(Heavy chain)
QVQLQESGPG LVKPSQTLSL TCTVSGGSIS SGDYFWSWIR QLPGKGLEWI GHIHNSGTTY
YNPSLKSRVT ISVDTSKKQF SLRLSSVTAA DTAVYYCARD RGGDYYYGMD VWGQGTTVTV
SSASTKGPSV FPLAPSSKST SGGTAALGCL VDKYFPEPVT VSWNSGALTS GVHTFPAVLQ
SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
YNSTYRVVSVLTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDLS
RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
(Light chain)
EIVLTQSPGT LSLSPGERAT LSCRASQGIS RSYLAWYQQK PGQAPSLLIY GASSRATGIP
DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QFGSSPWTFG QGTKVEIKRT VAAPSVFIFP
PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYLSSTL
TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
(Disulfide bridge: H22-H97, H49-H205, H266-H326, H372-H430, H231-H'231, H234-H'234, L23-L89, L135-L195, H225-L215, H'225-L'215; Glycosylation site: H302)
  Type
Peptide
Efficacy
Antineoplastic, TRAIL receptor 2 agonist
  Type
Monoclonal antibody
Target
TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF10B (TRAILR2, CD262)
     D09329  Conatumumab (USAN/INN)
Other DBs
CAS: 896731-82-1
PubChem: 96026009
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system